article thumbnail

Why COVID-19 patients who could most benefit from Paxlovid still aren’t getting it

American Nurse

Shrunken confidence in government health programs is one reason the drug isn’t reaching those who need it. 4 issued detailed instructions to health insurers urging swift approval of Paxlovid prescriptions, given the five-day window for the drug’s efficacy. Nursing home patients, who account for around 1 in 6 U.S.

Medicare 109